Skip to content
★ Sign in to follow
SG

Steven G. Brodie

Executive
Total declarations
8
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€494k

Latest filing published 24 Oct 2018 for Neogenomics INC, €40k.

Filing timeline

BuySale
Steven G. Brodie

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Steven G. Brodie: trading record in brief

All filings by Steven G. Brodie on record concern Neogenomics Inc. Between 10 March 2016 and 22 October 2018, the trades on record add up to 8 filings.

Every open-market trade on record is a sale: 3 sales worth €494k. The rest of the record consists of 1 share grant and 4 option exercises.

The latest filing, published on 24 October 2018, reports an option exercise of €40k in Neogenomics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Steven G. Brodie

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◇
    VP - Pharma OperationsExecutivesNeogenomics Inc
    46,002 USD19SEC
    13,334 shares@ US$3.45100.0% of flowCommon StockSEC:0001077183-18-000095:0
  • ◇
    Vice President of OperationsExecutivesNeogenomics Inc
    22,998 USD11SEC
    6,666 shares@ US$3.453.7% of flowCommon StockSEC:0001209191-17-044259:0
  • ◆
    President, Pharma ServicesExecutivesNeogenomics Inc
    37,600 USD23SEC
    10,000 shares@ US$3.766.3% of flowCommon StockSEC:0001209191-17-023160:0
  • ▼
    President, Pharma ServicesExecutivesNeogenomics Inc
    264,255 USD26SEC
    33,450 shares@ US$7.9044.9% of flowCommon StockSEC:0001209191-17-022294:1
  • ▼
    President, Pharma ServicesExecutivesNeogenomics Inc
    132,400 USD24SEC
    16,550 shares@ US$8.0022.6% of flowCommon StockSEC:0001209191-17-021567:0
  • ◇
    President, Pharma ServicesExecutivesNeogenomics Inc
    16,900 USD22SEC
    10,000 shares@ US$1.692.9% of flowCommon StockSEC:0001209191-16-153941:0
  • ◇
    Chief Scientific OfficerExecutivesNeogenomics Inc
    74,000 USD12SEC
    50,000 shares@ US$1.4812.3% of flowCommon StockSEC:0001209191-16-108163:0

7 of 7 declarations